1 / 3

European Dry Powdered Inhaler Market Trends, Size, Competitive Analysis and Fore

The European Dry Powdered Inhaler market was valued at around $3.7 billion in 2018 and is anticipated to grow at a substantial rate of 2.1% during the forecast period. Major countries that will contribute to the dry powdered inhaler market within the region includes UK, Germany, France, Italy, and Spain.

Meenoo
Télécharger la présentation

European Dry Powdered Inhaler Market Trends, Size, Competitive Analysis and Fore

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. European Dry Powdered Inhaler Market Growth, Size, Share, Industry Report and Forecast 2019-2025 The European Dry Powdered Inhaler market was valued at around $3.7 billion in 2018 and is anticipated to grow at a substantial rate of 2.1% during the forecast period. Major countries that will contribute to the dry powdered inhaler market within the region includes UK, Germany, France, Italy, and Spain. A significant number of companies, research, patient base has been observed in the market due to which a significant growth can be observed in the market. According to the International Monetary Fund (IMF), Europe is home to around 740 million people and the GDP of the European Union is $19.7 trillion in 2017. As per Organization for Economic Co-operation and Development (OECD), the self-reported asthma rate and COPD rate by European Union countries were 6.1% and 4.0% respectively and it has been found out that the rate of prevalence of diseases are higher in women as compared to men. This is expected to drive the regional business growth of the dry powdered inhaler market. To Request a Sample of our Report on European Dry Powdered Inhaler Market: https://www.omrglobal.com/request-sample/european-dry-powdered-inhaler-market The European dry powdered inhaler market is segmented based on type, application, and end-user. Based on the type, preventive, reliever, and long-acting bronchodilators inhaler are analyzed. The preventive dry powdered inhaler segment led the global dry powdered inhaler market in 2018. Preventive inhalers are most widely used in the treatment of asthma in children and adults. These inhalers do not entail side effects for long-term use, and exceptionally decreases the possibility of an asthma exacerbation. The preventive inhalers further reduce the airways swelling and hence, are recommended for regular use by the physician. Some of the preventive inhalers available in the market include Budesonide and Fluticasone. Moreover, based on the application, the market has been classified into asthma and COPD diseases. In addition, based on the end-user, homecare and hospitals and clinics have been analyzed. (Get 15% Discount on Buying this Report) A full Report of European Dry Powdered Inhaler Market is Available at: https://www.omrglobal.com/industry-reports/european-dry-powdered-inhaler-market European Dry Powdered Inhaler Market Segmentation By Type •Preventive Inhaler •Reliever Inhaler •Long Acting Bronchodilators Inhaler By Application •Asthma •Chronic Obstructive Pulmonary Disease (COPD)

  2. By End-User •Homecare •Hospitals and Clinics Regional Analysis •UK •Germany •France •Italy •Spain Rest of Europe Company Profiles •3M Co. •Acorda Therapeutics, Inc. •Adamis Pharmaceuticals Corp. •Adherium Ltd. •AstraZeneca PLC •Bespak •Boehringer Ingelheim International GmbH •Chiesi Farmaceutici S.P.A. •GF Health •GlaxoSmithKline PLC •H&T Presspart Manufacturing Ltd. •Koninklijke Philips N.V. •Novartis AG •Omron Healthcare Inc. •ResMed Corp. •Pulmatrix Inc. •Savara, Inc. •Teicos Pharma Ltd. •Teva Pharmaceuticals Industries Ltd. •Vitalograph Ltd. Reasons to Buying From us – 1. We cover more than 15 major industries, further segmented into more than 90 sectors. 2. More than 120 countries are for analysis. 3. Over 100+ paid data sources mined for investigation. 4. Our expert research analysts answer all your questions before and after purchasing your report. For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report- customization/european-dry-powdered-inhaler-market About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research- based services.

  3. For More Information, Visit Orion Market Research Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 7803040404

More Related